Tue. 16 Apr 2024, 9:01am ET
Benzinga
Biotech, News, General
Patent portfolio with over 100 patents, issued and pending, protects technology targeting a $100 billion market opportunity
Company developing potential breakthrough two-fold technology that can potentially detect problematic neural signals and ablate nerves in one simple procedure for pain management and other indications